{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T02:05:27Z","timestamp":1790301927956,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1124\/mol.109.061804","type":"journal-article","created":{"date-parts":[[2010,2,16]],"date-time":"2010-02-16T23:08:15Z","timestamp":1266361695000},"page":"836-845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Functional Characterization of Vasopressin Type 2 Receptor Substitutions (R137H\/C\/L) Leading to Nephrogenic Diabetes Insipidus and Nephrogenic Syndrome of Inappropriate Antidiuresis: Implications for Treatments"],"prefix":"10.1016","volume":"77","author":[{"given":"Moulay D.","family":"Rochdi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel A.","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Carpentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevi\u00e8ve","family":"Oligny-Longpr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanford","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham","family":"Kovoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E.","family":"Gitelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen M.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"von Zastrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Bouvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.109.061804_bib1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1258\/000456307781646030","article-title":"Vasopressin and disorders of water balance: the physiology and pathophysiology of vasopressin","volume":"44","author":"Ball","year":"2007","journal-title":"Ann Clin Biochem"},{"key":"10.1124\/mol.109.061804_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1073\/pnas.98.1.93","article-title":"Constitutive arrestin-mediated desensitization of a human vasopressin receptor mutant associated with nephrogenic diabetes insipidus","volume":"98","author":"Barak","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.109.061804_bib3","first-page":"17","article-title":"\u03b2-Arrestins: multifunctional cellular mediators","volume":"23","author":"Barki-Harrington","year":"2008","journal-title":"Physiology (Bethesda)"},{"key":"10.1124\/mol.109.061804_bib4","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.coph.2004.08.001","article-title":"Pharmacological chaperone action on G-protein-coupled receptors","volume":"4","author":"Bernier","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"10.1124\/mol.109.061804_bib5","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1210\/me.2004-0080","article-title":"Functional rescue of the constitutively internalized V2 vasopressin receptor mutant R137H by the pharmacological chaperone action of SR49059","volume":"18","author":"Bernier","year":"2004","journal-title":"Mol Endocrinol"},{"key":"10.1124\/mol.109.061804_bib6","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1681\/ASN.2005080854","article-title":"Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus","volume":"17","author":"Bernier","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/mol.109.061804_bib7","first-page":"278","article-title":"Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidus","volume":"55","author":"Bichet","year":"1994","journal-title":"Am J Hum Genet"},{"key":"10.1124\/mol.109.061804_bib8","doi-asserted-by":"crossref","first-page":"41541","DOI":"10.1074\/jbc.M306589200","article-title":"Palmitoylation of the V2 vasopressin receptor carboxyl tail enhances \u03b2-arrestin recruitment leading to efficient receptor endocytosis and ERK1\/2 activation","volume":"278","author":"Charest","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.109.061804_bib9","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1083\/jcb.127.4.915","article-title":"Induction of mutant dynamin specifically blocks endocytic coated vesicle formation","volume":"127","author":"Damke","year":"1994","journal-title":"J Cell Biol"},{"key":"10.1124\/mol.109.061804_bib10","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1681\/ASN.2006090987","article-title":"Nephrogenic syndrome of inappropriate antidiuresis in adults: high phenotypic variability in men and women from a large pedigree","volume":"18","author":"Decaux","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/mol.109.061804_bib11","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1056\/NEJMoa042743","article-title":"Nephrogenic syndrome of inappropriate antidiuresis","volume":"352","author":"Feldman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1124\/mol.109.061804_bib12","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1210\/jc.2002-020501","article-title":"Clinical, genetic, and functional characterization of adrenocorticotropin receptor mutations using a novel receptor assay","volume":"87","author":"Fl\u00fcck","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1124\/mol.109.061804_bib13","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1681\/ASN.2005040371","article-title":"Molecular biology of hereditary diabetes insipidus","volume":"16","author":"Fujiwara","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/mol.109.061804_bib14","doi-asserted-by":"crossref","first-page":"44712","DOI":"10.1074\/jbc.M107417200","article-title":"A transplantable sorting signal that is sufficient to mediate rapid recycling of G protein-coupled receptors","volume":"276","author":"Gage","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.109.061804_bib15","doi-asserted-by":"crossref","first-page":"29089","DOI":"10.1074\/jbc.M700577200","article-title":"Unraveling G protein-coupled receptor endocytosis pathways using real-time monitoring of agonist-promoted interaction between \u03b2-arrestins and AP-2","volume":"282","author":"Hamdan","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.109.061804_bib16","doi-asserted-by":"crossref","first-page":"17442","DOI":"10.1074\/jbc.M009214200","article-title":"Heterologous inhibition of G protein-coupled receptor endocytosis mediated by receptor-specific trafficking of \u03b2-arrestins","volume":"276","author":"Klein","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.109.061804_bib17","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1210\/me.2008-0321","article-title":"Agonist-independent interactions between \u03b2-arrestins and mutant vasopressin type II receptors associated with nephrogenic syndrome of inappropriate antidiuresis","volume":"23","author":"Kocan","year":"2009","journal-title":"Mol Endocrinol"},{"key":"10.1124\/mol.109.061804_bib18","doi-asserted-by":"crossref","first-page":"27605","DOI":"10.1074\/jbc.272.44.27605","article-title":"\u03bc and \u03b4 Opioid receptors are differentially desensitized by the coexpression of \u03b2-adrenergic receptor kinase 2 and \u03b2-arrestin 2 in Xenopus oocytes","volume":"272","author":"Kovoor","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.109.061804_bib19","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1085\/jgp.105.3.421","article-title":"A G protein-gated K channel is activated via \u03b22-adrenergic receptors and G\u03b2\u03b3 subunits in Xenopus oocytes","volume":"105","author":"Lim","year":"1995","journal-title":"J Gen Physiol"},{"key":"10.1124\/mol.109.061804_bib20","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1146\/annurev.physiol.63.1.607","article-title":"Nephrogenic diabetes insipidus","volume":"63","author":"Morello","year":"2001","journal-title":"Annu Rev Physiol"},{"key":"10.1124\/mol.109.061804_bib21","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1172\/JCI8688","article-title":"Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants","volume":"105","author":"Morello","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1124\/mol.109.061804_bib22","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0014-5793(98)01585-3","article-title":"The D136A mutation of the V2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activities","volume":"441","author":"Morin","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1124\/mol.109.061804_bib23","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1677\/erc.1.00803","article-title":"Oxytocin- and vasopressin-induced growth of human small-cell lung cancer is mediated by the mitogen-activated protein kinase pathway","volume":"11","author":"P\u00e9queux","year":"2004","journal-title":"Endocr Relat Cancer"},{"key":"10.1124\/mol.109.061804_bib24","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2265.2008.03513.x","article-title":"Identification, characterization, and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus","volume":"71","author":"Ranadive","year":"2009","journal-title":"Clin Endocrinol"},{"key":"10.1124\/mol.109.061804_bib25","doi-asserted-by":"crossref","first-page":"17827","DOI":"10.1074\/jbc.M210319200","article-title":"G\u03b1q-coupled receptor internalization specifically induced by G\u03b1q signaling. Regulation by EBP50","volume":"278","author":"Rochdi","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.109.061804_bib26","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/157488906777452730","article-title":"Development of new drugs that act through membrane receptors and involve an action of inverse agonism","volume":"1","author":"Rodr\u00edguez-Puertas","year":"2006","journal-title":"Recent Patents CNS Drug Discov"},{"key":"10.1124\/mol.109.061804_bib27","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1124\/mol.106.029470","article-title":"The highly conserved DRY motif of class A G protein-coupled receptors: beyond the ground state","volume":"71","author":"Rovati","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.109.061804_bib28","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/jcp.21552","article-title":"AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance","volume":"217","author":"Spanakis","year":"2008","journal-title":"J Cell Physiol"},{"key":"10.1124\/mol.109.061804_bib29","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3109\/10799899909036660","article-title":"Development of a dual glow-signal firefly and Renilla luciferase assay reagent for the analysis of G protein-coupled receptor signalling","volume":"19","author":"Stables","year":"1999","journal-title":"J Recept Signal Transduct Res"},{"key":"10.1124\/mol.109.061804_bib30","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00000542-200609000-00026","article-title":"The vasopressin system: physiology and clinical strategies","volume":"105","author":"Treschan","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1124\/mol.109.061804_bib31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1172\/JCI9238","article-title":"Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity","volume":"106","author":"Vaisse","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1124\/mol.109.061804_bib32","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0303-7207(96)03926-3","article-title":"Functional characterization of five V2 vasopressin receptor gene mutations","volume":"124","author":"Wenkert","year":"1996","journal-title":"Mol Cell Endocrinol"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24026762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24026762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.109.061804","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T04:45:01Z","timestamp":1739940301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24026762"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0026895X24026762"],"URL":"https:\/\/doi.org\/10.1124\/mol.109.061804","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.7298958.7552056","asserted-by":"object"}]},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional Characterization of Vasopressin Type 2 Receptor Substitutions (R137H\/C\/L) Leading to Nephrogenic Diabetes Insipidus and Nephrogenic Syndrome of Inappropriate Antidiuresis: Implications for Treatments","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.109.061804","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}